Projects per year
Personal profile
Education
- 1996 Ph.D. (Public Health), School of Hygiene and Public Health Johns Hopkins University
- 1987 B.A. (International Business), National Taiwan University
Experience
- 2007 Professor, School of Health Care Administration, Taipei Mdical University
- 1997 Associate Professor, School of Health Care Administration, Taipei Mdical University
Research Interests
- Health Economics
- Economic Evaluation
Fingerprint
Dive into the research topics where Chao-Hsiun Tang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 14 Finished
-
台灣全民健保下醫療財務災難率的趨勢分析
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
全民健康保險思覺失調症醫療給付改善方案之成效評估
7/1/17 → 2/28/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
台灣創新癌症藥物使用量與費用支出之趨勢分析：回溯觀察性研究
7/1/17 → 2/28/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Evaluation on Cervical Cancer Prevention and Treatment Policy in Taiwan
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
末期腎臟病人接受不同透析治療方式之成本效益分析
5/1/15 → 4/30/16
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
Research output
-
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
Liu, Y., Tang, C-H., Qiu, H., Siggins, S. & Hou, H-A., Jan 13 2021, In: Scientific Reports. 11, 1, p. 1112Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
Liu, Y., Hou, H-A., Qiu, H. & Tang, C-H., Sep 1 2020, In: Scientific Reports. 10, 1, p. 14393Research output: Contribution to journal › Article › peer-review
-
Prevalence of baseline comorbidities in patients with atopic dermatitis: A population-based cohort study in Taiwan
Cho, Y-T., Hsieh, W-T., Chan, T. C., Tang, C-H. & Chu, C-Y., 2020, In: JAAD International. 1, 1, p. 50-58 9 p.Research output: Contribution to journal › Article › peer-review
-
Treatment evolution and improved survival in multiple myeloma in Taiwan
Tang, C. H., Hou, H. A., Huang, K. C., Qiu, H. & Liu, Y., Feb 1 2020, In: Annals of Hematology. 99, 2, p. 321-330 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Comparison of healthcare utilization and costs between RA patients receiving biological and conventional synthetic DMARDs: A nationwide population-based cohort study in Taiwan
Chen, D. Y., Yu, F., Tuan, L. W. & Tang, C. H., Jan 1 2019, In: Frontiers in Pharmacology. 10, 1214.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
Factors affecting discontinuation of adalimumab and etanercept therapy in anti-TNF-naïve patients with ankylosing spondylitis: Nationwide population-based cohort study
Chen, H. (Contributor), Chen, Y. (Contributor), Lai, K. (Contributor), Lin, C. (Contributor), Tang, C. (Contributor) & Chen, D. (Contributor), Unknown Publisher, Sep 8 2015
DOI: 10.6084/m9.figshare.1601856.v1, https://tandf.figshare.com/articles/journal_contribution/Factors_affecting_discontinuation_of_adalimumab_and_etanercept_therapy_in_anti_TNF_na_239_ve_patients_with_ankylosing_spondylitis_Nationwide_population_based_cohort_study/1601856/1
Dataset
-
Protein-energy wasting significantly increases healthcare utilization and costs among patients with chronic kidney disease: a propensity-score matched cohort study
Chao, C. (Contributor), Tang, C. (Contributor), Cheng, R. W. (Contributor), Wang, M. Y. (Contributor) & Hung, K. (Contributor), Unknown Publisher, Sep 2 2017
DOI: 10.6084/m9.figshare.5198317.v1, https://tandf.figshare.com/articles/figure/Protein-energy_wasting_significantly_increases_healthcare_utilization_and_costs_among_patients_with_chronic_kidney_disease_a_propensity-score_matched_cohort_study/5198317/1
Dataset
-
A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
Chiu, Y. (Contributor), Tang, C. (Contributor), Hung, S. (Contributor), Yang, Y. (Contributor), Fang, C. (Contributor) & Lin, H. (Contributor), Unknown Publisher, May 4 2017
DOI: 10.6084/m9.figshare.4047471.v1, https://tandf.figshare.com/articles/journal_contribution/A_real-world_risk_analysis_of_biological_treatment_adalimumab_and_etanercept_in_a_country_with_a_high_prevalence_of_tuberculosis_and_chronic_liver_disease_a_nationwide_population-based_study/4047471/1
Dataset